How to Be Safer As You Live Longer: A Patient Checklist

As we continue to fight for the development of and access to new and better drugs, increasing numbers of myeloma patients are already living longer—certainly beyond 5 years, and often beyond 10 to 15 years. That’s certainly great news! But long-living myeloma patients need specialized care plans. Here’s a checklist to help those patients stay alert to red flags which call for special attention:

Knowledge Is Power – Especially When Choosing What to Eat

There is always something in the news about what to eat or drink. Eat this. Don’t drink that. You will get cancer. You won’t get cancer. What is one to do?

Can polio or other viruses treat myeloma?

A segment on last Sunday’s edition of the CBS news show 60 Minutes illustrated how the injection of polio virus into brain tumors can be dramatically effective.

Is it possible to boost the immune system for myeloma patients?

The answer is a definite maybe! As myeloma evolves, it does so within the complex immune microenvironment of the bone marrow. The most well-known impact is the reduction in normal plasma cells and reductions in normal immunoglobulin production, causing reduced normal gamma globulins as part of the SPEP (serum protein electrophoresis) pattern. But there are many other effects of the disease which result in reduced or abnormal immune responses. The most well-documented feature of myeloma is the reduced ability to fight infections.

What Is the Solution for the Rising Cost of Cancer Drugs?

In the current issue of the Mayo Clinic Proceedings, Hagop Kantarjian, MD and S. Vincent Rajkumar, MD discuss the high cost of cancer drugs and propose some solutions. The high cost of cancer drugs is widely known. Unfortunately, this new article does not provide solutions that have an immediate chance of implementation and/or success.